DrugCite
Search

CGP

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Cgp Adverse Events Reported to the FDA Over Time

How are Cgp adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Cgp, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Cgp is flagged as the suspect drug causing the adverse event.

Most Common Cgp Adverse Events Reported to the FDA

What are the most common Cgp adverse events reported to the FDA?

Pyrexia
39 (1.76%)
Dyspnoea
37 (1.67%)
Nausea
31 (1.4%)
Pleural Effusion
31 (1.4%)
Oedema Peripheral
30 (1.36%)
Diarrhoea
26 (1.18%)
Haemoglobin Decreased
25 (1.13%)
Asthenia
24 (1.08%)
Death
24 (1.08%)
Abdominal Pain
22 (.99%)
Fatigue
22 (.99%)
Show More Show More
Lung Infiltration
22 (.99%)
Neutropenia
21 (.95%)
General Physical Health Deteriorati...
20 (.9%)
Blood Creatinine Increased
19 (.86%)
Vomiting
19 (.86%)
Pain In Extremity
18 (.81%)
Pneumonia
18 (.81%)
Thrombocytopenia
18 (.81%)
Anaemia
17 (.77%)
Dehydration
17 (.77%)
Myalgia
17 (.77%)
Hypertension
16 (.72%)
Febrile Neutropenia
14 (.63%)
Neoplasm Malignant
14 (.63%)
Cardiac Failure Congestive
13 (.59%)
Confusional State
13 (.59%)
Drug Exposure During Pregnancy
13 (.59%)
Headache
13 (.59%)
Malignant Neoplasm Progression
13 (.59%)
Pulmonary Embolism
13 (.59%)
Tachycardia
13 (.59%)
Cardiac Failure
12 (.54%)
Chills
12 (.54%)
Cough
12 (.54%)
Oxygen Saturation Decreased
12 (.54%)
Respiratory Failure
12 (.54%)
Atrial Fibrillation
11 (.5%)
Fall
11 (.5%)
Hypoxia
11 (.5%)
Loss Of Consciousness
11 (.5%)
Sepsis
11 (.5%)
Cardiac Disorder
10 (.45%)
Endotracheal Intubation
10 (.45%)
Eyelid Oedema
10 (.45%)
Face Oedema
10 (.45%)
Muscle Spasms
10 (.45%)
Renal Disorder
10 (.45%)
Renal Failure
10 (.45%)
Renal Failure Acute
10 (.45%)
Septic Shock
10 (.45%)
Surgery
10 (.45%)
Rhabdomyolysis
9 (.41%)
Atrial Flutter
8 (.36%)
Blood Creatine Phosphokinase Increa...
8 (.36%)
Cardiomyopathy
8 (.36%)
Clostridial Infection
8 (.36%)
Left Ventricular Dysfunction
8 (.36%)
Lung Consolidation
8 (.36%)
Malaise
8 (.36%)
Neuralgia
8 (.36%)
Palatal Disorder
8 (.36%)
Photosensitivity Reaction
8 (.36%)
Rash Erythematous
8 (.36%)
Renin Increased
8 (.36%)
Snoring
8 (.36%)
Somnolence
8 (.36%)
Tachyarrhythmia
8 (.36%)
Abortion Induced
7 (.32%)
Acute Respiratory Distress Syndrome
7 (.32%)
Blood Glucose Increased
7 (.32%)
Blood Pressure Decreased
7 (.32%)
Central Venous Catheterisation
7 (.32%)
Erythema
7 (.32%)
Inflammation
7 (.32%)
Lung Neoplasm
7 (.32%)
Malnutrition
7 (.32%)
Muscular Weakness
7 (.32%)
Pancytopenia
7 (.32%)
Pericardial Effusion
7 (.32%)
Post Procedural Haemorrhage
7 (.32%)
Staphylococcal Infection
7 (.32%)
Aphasia
6 (.27%)
Benign Prostatic Hyperplasia
6 (.27%)
Bronchopneumonia
6 (.27%)
Cardio-respiratory Arrest
6 (.27%)
Chest Pain
6 (.27%)
Coma
6 (.27%)
Concomitant Disease Progression
6 (.27%)
Dacryostenosis Acquired
6 (.27%)
Dysuria
6 (.27%)
Gait Disturbance
6 (.27%)
Haematoma
6 (.27%)
Hepatic Enzyme Increased
6 (.27%)
Hypotension
6 (.27%)
Influenza
6 (.27%)
Lung Disorder
6 (.27%)
Mass
6 (.27%)
Neurological Symptom
6 (.27%)
Oesophagitis
6 (.27%)
Pain
6 (.27%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Cgp, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Cgp is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Cgp

What are the most common Cgp adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Cgp, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Cgp is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Cgp According to Those Reporting Adverse Events

Why are people taking Cgp, according to those reporting adverse events to the FDA?

Chronic Myeloid Leukaemia
106
Gastrointestinal Stromal Tumour
52
Malaria
24
Acute Lymphocytic Leukaemia
17
Acute Myeloid Leukaemia
16
Metastases To Bone
10
Show More Show More
Systemic Sclerosis
6
Bronchitis
4
Glioblastoma Multiforme
4
Synovitis
4
Chronic Graft Versus Host Disease
4
Myelodysplastic Syndrome
3
Iron Overload
3
Asthma
3
Graft Versus Host Disease
3
Breast Cancer
3
Chordoma
2
Small Cell Lung Cancer Stage Unspec...
2
Chronic Obstructive Pulmonary Disea...
2
Hypertension
2
Bile Duct Cancer
2
Breast Cancer Metastatic
2
Sickle Cell Anaemia
2
Lung Disorder
2
Blast Crisis In Myelogenous Leukaem...
1
Hypereosinophilic Syndrome
1
Prostate Cancer
1
Glioblastoma
1
Multiple Myeloma
1
Colorectal Cancer
1
Allergic Cough
1
Sarcoma
1
Lymphatic Disorder
1
Aplastic Anaemia
1
Non-small Cell Lung Cancer
1
Large Intestine Carcinoma
1
Blood Disorder
1
Ovarian Neoplasm
1

Cgp Case Reports

What Cgp safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Cgp. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Cgp.